IQVIA Holdings Inc.

IQV Healthcare Diagnostics & Research

IQVIA Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $16.3 billion, up 5.87% from fiscal 2024. In the quarter to June 2026, revenue grew 8.74%, EPS was flat, free cash flow grew 23.3% and total debt rose 3.29%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for ten consecutive years.

266.90 4.14 −1.53%
Market cap
$44.6B
P/E
32.8×
Fwd P/E
22.3×
Dividend yield
—
F-score
4/9
Altman Z
2.05
Beneish M
−2.59
Dividend safety
n/a

IQVIA Holdings Inc. (IQV) Operating cash flow

Alert me on Operating cash flow

IQVIA Holdings Inc.'s operating cash flow for fiscal 2025 was $2.7B, unchanged from fiscal 2024. Over the twelve months to 30 June 2026 it was $2.8B. Over the past ten years it has ranged from $476.0M (fiscal 2015) to $2.9B (fiscal 2021); the current reading is higher than 82% of that period. IQVIA Holdings Inc. ranks 3rd of 52 Diagnostics & Research companies by operating cash flow.

Operating cash flow, annual

Embed this chart

Annual newest first

Period Operating cash flow Change
FY2025 $2.7B (2.28%)
FY2024 $2.7B 26.38%
FY2023 $2.1B (4.91%)
FY2022 $2.3B (23.18%)
FY2021 $2.9B 50.18%
FY2020 $2.0B 38.25%
FY2019 $1.4B 13.00%
FY2018 $1.3B 29.28%
FY2017 $970.0M 12.79%
FY2016 $860.0M 80.67%

Quarterly newest first

Period Operating cash flow Change
Jun 2026 $558.0M (9.71%)
Mar 2026 $618.0M (15.92%)
Dec 2025 $735.0M (19.05%)
Sep 2025 $908.0M 104.97%
42 more quarters

Against its own ten years

Low $476.0M High $2.9B
Ten-year median $2.0B
Current reading's percentile 82

Operating cash flow against peers

What Operating cash flow is

Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.

Reported line item

The full definition of Operating cash flow →

More on IQV